Skip to content

To study the effect of Nirgundi Guggulu in the treatment of Avabahuka(Frozen shoulder).

An Exploratory Clinical study to evaluate the efficacy of Nirgundi Guggulu in the management of Avabahuka - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058753
Enrollment
35
Registered
2023-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M256- Stiffness of joint, not elsewhereclassified

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient presenting with the classical signs and symptoms of Avabahuka i.e Amsa shoola ,amsa sandhi graha ,amsa sandhi kriyalpata 2.Patients of either sex,caste, religions, economical status and age between 30 to 60 years

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating mothers. 2 Patient suffering from major trauma having dislocation, Rotator cuff injury or fracture. 3 Patient suffering from any major systemic disorders like, Hypertension, Ischemic Heart disease, Gout, rheumatoid arthritis, pulmonary disorder. 4 Those patients who need other emergency interventions like surgery and other means are excluded. 5 History of surgery at shoulder joint, clavicle and vertebral column. 6 K/C/O HIV, HBsAg, tuberculosis of bone. 7 Patient with Malignancy and Immuno-compromised disorders. 8 Patients with uncontrolled Diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
1 To evaluate the efficacy of Nirgundi Guggulu 500 mg 2 tab 2 times a day after meals with lukewarm water in Avabahuka from 21days. 2 To give maximum symptomatic relief from symptoms of Avabahuka like amsa sandhi shoola, Amsa sandhi kriyalpata, Amsa sandhi graha within 21 days of treatment.Timepoint: 21 days study with 3 follow ups on 7 th,14 th and 21 days

Secondary

MeasureTime frame
To study the adverse drug effects if anyTimepoint: 21 days study with 3 follows on 7 th,14 th and 21 days

Countries

India

Contacts

Public ContactDr Rupali Khobragade

PDEAs College of Ayurved and Research Centre,Nigdi Pune

khobragaderupali19@gmail.com8378929859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026